VorteFri Original

VorteFri (known as EndWarts in some regions) is a specialized topical treatment for warts on hands, feet, elbows, and knees. The brand originated in Sweden, developed under the pharmaceutical company Meda Aktiebolag. It gained international prominence for its formic acid-based formula that effectively dehydrates warts from the inside.

In 2016, the Swedish parent company Meda was acquired by the global pharmaceutical giant Mylan in a multi-billion dollar deal. Subsequently, in 2020, Mylan merged with Pfizer's Upjohn division to form Viatris Inc., which now serves as the ultimate owner of the brand. Viatris is headquartered in the United States and manages the production through an extensive network of global manufacturing facilities across Europe and North America. While the brand remains deeply rooted in Scandinavian health standards, its distribution and manufacturing are now part of a vast global healthcare infrastructure.